Patent intelligence · AT
AT E194345
XANTHINDERIVATE
XANTHINDERIVATE
Patent details — AT E194345
- Jurisdiction
- AT
- Status
- expired
- Grant date
- Jul 15, 2000
- Expiration
- Jul 10, 2020
- Applicant
- BEECHAM GROUP PLC [GB]
- CPC classes
- A61K 31/ 52 A I, A61K 31/ 522 A I, A61P 37/ 08 A I, A61P/3708
Quick answer
AT E194345 (XANTHINDERIVATE) is held by BEECHAM GROUP PLC [GB]. Status: expired. Granted Jul 15, 2000. Expires Jul 10, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BEECHAM GROUP PLC [GB]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 52 A I, A61K 31/ 522 A I, A61P 37/ 08 A I, A61P/3708
More from BEECHAM GROUP PLC [GB]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
expired -
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
HK 1004528
Dentifrice compositions
expired -
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
expired
Frequently asked questions
What is US patent E194345?
AT E194345 (XANTHINDERIVATE) is held by BEECHAM GROUP PLC [GB]. Status: expired. Granted Jul 15, 2000. Expires Jul 10, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AT E194345?
BEECHAM GROUP PLC [GB] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does AT E194345 expire?
Our index shows an expiration date of Jul 10, 2020 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.